img

Global T-Cell Immunotherapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global T-Cell Immunotherapy Market Insights, Forecast to 2034

CAR T cell therapy is a type of cancer immunotherapy treatment that uses immune cells called T cells that are genetically altered in a lab to enable them in locating in destroying cancer cells more effectively.
Market Analysis and InsightsGlobal T-Cell Immunotherapy Market
Global T-Cell Immunotherapy market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, T-Cell Immunotherapy industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global T-Cell Immunotherapy market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global T-Cell Immunotherapy market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Adaptimmune
Altor Bioscience Corporation
Cellectis
Juno Therapeutics
Kite Pharma
Novartis
Takara Bio
Unum Therapeutics
Segment by Type
CAR-T
TCR
TIL Therapies

Segment by Application


Stomach Cancer
Lung Cancer
Colorectal Cancer
Esophagus Cancer
Pancreatic Cancer
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, T-Cell Immunotherapy introduction, etc. T-Cell Immunotherapy Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of T-Cell Immunotherapy
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global T-Cell Immunotherapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 CAR-T
1.2.3 TCR
1.2.4 TIL Therapies
1.3 Market by Application
1.3.1 Global T-Cell Immunotherapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Stomach Cancer
1.3.3 Lung Cancer
1.3.4 Colorectal Cancer
1.3.5 Esophagus Cancer
1.3.6 Pancreatic Cancer
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global T-Cell Immunotherapy Market Perspective (2018-2033)
2.2 Global T-Cell Immunotherapy Growth Trends by Region
2.2.1 T-Cell Immunotherapy Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 T-Cell Immunotherapy Historic Market Size by Region (2018-2023)
2.2.3 T-Cell Immunotherapy Forecasted Market Size by Region (2024-2033)
2.3 T-Cell Immunotherapy Market Dynamics
2.3.1 T-Cell Immunotherapy Industry Trends
2.3.2 T-Cell Immunotherapy Market Drivers
2.3.3 T-Cell Immunotherapy Market Challenges
2.3.4 T-Cell Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue T-Cell Immunotherapy by Players
3.1.1 Global T-Cell Immunotherapy Revenue by Players (2018-2023)
3.1.2 Global T-Cell Immunotherapy Revenue Market Share by Players (2018-2023)
3.2 Global T-Cell Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of T-Cell Immunotherapy, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global T-Cell Immunotherapy Market Concentration Ratio
3.4.1 Global T-Cell Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by T-Cell Immunotherapy Revenue in 2022
3.5 Global Key Players of T-Cell Immunotherapy Head office and Area Served
3.6 Global Key Players of T-Cell Immunotherapy, Product and Application
3.7 Global Key Players of T-Cell Immunotherapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 T-Cell Immunotherapy Breakdown Data by Type
4.1 Global T-Cell Immunotherapy Historic Market Size by Type (2018-2023)
4.2 Global T-Cell Immunotherapy Forecasted Market Size by Type (2024-2033)
5 T-Cell Immunotherapy Breakdown Data by Application
5.1 Global T-Cell Immunotherapy Historic Market Size by Application (2018-2023)
5.2 Global T-Cell Immunotherapy Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America T-Cell Immunotherapy Market Size (2018-2033)
6.2 North America T-Cell Immunotherapy Market Size by Type
6.2.1 North America T-Cell Immunotherapy Market Size by Type (2018-2023)
6.2.2 North America T-Cell Immunotherapy Market Size by Type (2024-2033)
6.2.3 North America T-Cell Immunotherapy Market Share by Type (2018-2033)
6.3 North America T-Cell Immunotherapy Market Size by Application
6.3.1 North America T-Cell Immunotherapy Market Size by Application (2018-2023)
6.3.2 North America T-Cell Immunotherapy Market Size by Application (2024-2033)
6.3.3 North America T-Cell Immunotherapy Market Share by Application (2018-2033)
6.4 North America T-Cell Immunotherapy Market Size by Country
6.4.1 North America T-Cell Immunotherapy Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America T-Cell Immunotherapy Market Size by Country (2018-2023)
6.4.3 North America T-Cell Immunotherapy Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe T-Cell Immunotherapy Market Size (2018-2033)
7.2 Europe T-Cell Immunotherapy Market Size by Type
7.2.1 Europe T-Cell Immunotherapy Market Size by Type (2018-2023)
7.2.2 Europe T-Cell Immunotherapy Market Size by Type (2024-2033)
7.2.3 Europe T-Cell Immunotherapy Market Share by Type (2018-2033)
7.3 Europe T-Cell Immunotherapy Market Size by Application
7.3.1 Europe T-Cell Immunotherapy Market Size by Application (2018-2023)
7.3.2 Europe T-Cell Immunotherapy Market Size by Application (2024-2033)
7.3.3 Europe T-Cell Immunotherapy Market Share by Application (2018-2033)
7.4 Europe T-Cell Immunotherapy Market Size by Country
7.4.1 Europe T-Cell Immunotherapy Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe T-Cell Immunotherapy Market Size by Country (2018-2023)
7.4.3 Europe T-Cell Immunotherapy Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China T-Cell Immunotherapy Market Size (2018-2033)
8.2 China T-Cell Immunotherapy Market Size by Type
8.2.1 China T-Cell Immunotherapy Market Size by Type (2018-2023)
8.2.2 China T-Cell Immunotherapy Market Size by Type (2024-2033)
8.2.3 China T-Cell Immunotherapy Market Share by Type (2018-2033)
8.3 China T-Cell Immunotherapy Market Size by Application
8.3.1 China T-Cell Immunotherapy Market Size by Application (2018-2023)
8.3.2 China T-Cell Immunotherapy Market Size by Application (2024-2033)
8.3.3 China T-Cell Immunotherapy Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia T-Cell Immunotherapy Market Size (2018-2033)
9.2 Asia T-Cell Immunotherapy Market Size by Type
9.2.1 Asia T-Cell Immunotherapy Market Size by Type (2018-2023)
9.2.2 Asia T-Cell Immunotherapy Market Size by Type (2024-2033)
9.2.3 Asia T-Cell Immunotherapy Market Share by Type (2018-2033)
9.3 Asia T-Cell Immunotherapy Market Size by Application
9.3.1 Asia T-Cell Immunotherapy Market Size by Application (2018-2023)
9.3.2 Asia T-Cell Immunotherapy Market Size by Application (2024-2033)
9.3.3 Asia T-Cell Immunotherapy Market Share by Application (2018-2033)
9.4 Asia T-Cell Immunotherapy Market Size by Region
9.4.1 Asia T-Cell Immunotherapy Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia T-Cell Immunotherapy Market Size by Region (2018-2023)
9.4.3 Asia T-Cell Immunotherapy Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Adaptimmune
11.1.1 Adaptimmune Company Details
11.1.2 Adaptimmune Business Overview
11.1.3 Adaptimmune T-Cell Immunotherapy Introduction
11.1.4 Adaptimmune Revenue in T-Cell Immunotherapy Business (2018-2023)
11.1.5 Adaptimmune Recent Developments
11.2 Altor Bioscience Corporation
11.2.1 Altor Bioscience Corporation Company Details
11.2.2 Altor Bioscience Corporation Business Overview
11.2.3 Altor Bioscience Corporation T-Cell Immunotherapy Introduction
11.2.4 Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2018-2023)
11.2.5 Altor Bioscience Corporation Recent Developments
11.3 Cellectis
11.3.1 Cellectis Company Details
11.3.2 Cellectis Business Overview
11.3.3 Cellectis T-Cell Immunotherapy Introduction
11.3.4 Cellectis Revenue in T-Cell Immunotherapy Business (2018-2023)
11.3.5 Cellectis Recent Developments
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics T-Cell Immunotherapy Introduction
11.4.4 Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2018-2023)
11.4.5 Juno Therapeutics Recent Developments
11.5 Kite Pharma
11.5.1 Kite Pharma Company Details
11.5.2 Kite Pharma Business Overview
11.5.3 Kite Pharma T-Cell Immunotherapy Introduction
11.5.4 Kite Pharma Revenue in T-Cell Immunotherapy Business (2018-2023)
11.5.5 Kite Pharma Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis T-Cell Immunotherapy Introduction
11.6.4 Novartis Revenue in T-Cell Immunotherapy Business (2018-2023)
11.6.5 Novartis Recent Developments
11.7 Takara Bio
11.7.1 Takara Bio Company Details
11.7.2 Takara Bio Business Overview
11.7.3 Takara Bio T-Cell Immunotherapy Introduction
11.7.4 Takara Bio Revenue in T-Cell Immunotherapy Business (2018-2023)
11.7.5 Takara Bio Recent Developments
11.8 Unum Therapeutics
11.8.1 Unum Therapeutics Company Details
11.8.2 Unum Therapeutics Business Overview
11.8.3 Unum Therapeutics T-Cell Immunotherapy Introduction
11.8.4 Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2018-2023)
11.8.5 Unum Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global T-Cell Immunotherapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of CAR-T
Table 3. Key Players of TCR
Table 4. Key Players of TIL Therapies
Table 5. Global T-Cell Immunotherapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 6. Global T-Cell Immunotherapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global T-Cell Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global T-Cell Immunotherapy Market Share by Region (2018-2023)
Table 9. Global T-Cell Immunotherapy Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 10. Global T-Cell Immunotherapy Market Share by Region (2024-2033)
Table 11. T-Cell Immunotherapy Market Trends
Table 12. T-Cell Immunotherapy Market Drivers
Table 13. T-Cell Immunotherapy Market Challenges
Table 14. T-Cell Immunotherapy Market Restraints
Table 15. Global T-Cell Immunotherapy Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global T-Cell Immunotherapy Revenue Share by Players (2018-2023)
Table 17. Global Top T-Cell Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2022)
Table 18. Global T-Cell Immunotherapy Industry Ranking 2021 VS 2022 VS 2023
Table 19. Global 5 Largest Players Market Share by T-Cell Immunotherapy Revenue (CR5 and HHI) & (2018-2023)
Table 20. Global Key Players of T-Cell Immunotherapy, Headquarters and Area Served
Table 21. Global Key Players of T-Cell Immunotherapy, Product and Application
Table 22. Global Key Players of T-Cell Immunotherapy, Product and Application
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global T-Cell Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global T-Cell Immunotherapy Revenue Market Share by Type (2018-2023)
Table 26. Global T-Cell Immunotherapy Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 27. Global T-Cell Immunotherapy Revenue Market Share by Type (2024-2033)
Table 28. Global T-Cell Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global T-Cell Immunotherapy Revenue Share by Application (2018-2023)
Table 30. Global T-Cell Immunotherapy Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 31. Global T-Cell Immunotherapy Revenue Share by Application (2024-2033)
Table 32. North America T-Cell Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 33. North America T-Cell Immunotherapy Market Size by Type (2024-2033) & (US$ Million)
Table 34. North America T-Cell Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 35. North America T-Cell Immunotherapy Market Size by Application (2024-2033) & (US$ Million)
Table 36. North America T-Cell Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. North America T-Cell Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 38. North America T-Cell Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 39. Europe T-Cell Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 40. Europe T-Cell Immunotherapy Market Size by Type (2024-2033) & (US$ Million)
Table 41. Europe T-Cell Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 42. Europe T-Cell Immunotherapy Market Size by Application (2024-2033) & (US$ Million)
Table 43. Europe T-Cell Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Europe T-Cell Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 45. Europe T-Cell Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 46. China T-Cell Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 47. China T-Cell Immunotherapy Market Size by Type (2024-2033) & (US$ Million)
Table 48. China T-Cell Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 49. China T-Cell Immunotherapy Market Size by Application (2024-2033) & (US$ Million)
Table 50. Asia T-Cell Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 51. Asia T-Cell Immunotherapy Market Size by Type (2024-2033) & (US$ Million)
Table 52. Asia T-Cell Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 53. Asia T-Cell Immunotherapy Market Size by Application (2024-2033) & (US$ Million)
Table 54. Asia T-Cell Immunotherapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 55. Asia T-Cell Immunotherapy Market Size by Region (2018-2023) & (US$ Million)
Table 56. Asia T-Cell Immunotherapy Market Size by Region (2024-2033) & (US$ Million)
Table 57. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Type (2018-2023) & (US$ Million)
Table 58. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Type (2024-2033) & (US$ Million)
Table 59. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Application (2018-2023) & (US$ Million)
Table 60. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Application (2024-2033) & (US$ Million)
Table 61. Middle East, Africa, and Latin America T-Cell Immunotherapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 62. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Country (2018-2023) & (US$ Million)
Table 63. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size by Country (2024-2033) & (US$ Million)
Table 64. Adaptimmune Company Details
Table 65. Adaptimmune Business Overview
Table 66. Adaptimmune T-Cell Immunotherapy Product
Table 67. Adaptimmune Revenue in T-Cell Immunotherapy Business (2018-2023) & (US$ Million)
Table 68. Adaptimmune Recent Developments
Table 69. Altor Bioscience Corporation Company Details
Table 70. Altor Bioscience Corporation Business Overview
Table 71. Altor Bioscience Corporation T-Cell Immunotherapy Product
Table 72. Altor Bioscience Corporation Revenue in T-Cell Immunotherapy Business (2018-2023) & (US$ Million)
Table 73. Altor Bioscience Corporation Recent Developments
Table 74. Cellectis Company Details
Table 75. Cellectis Business Overview
Table 76. Cellectis T-Cell Immunotherapy Product
Table 77. Cellectis Revenue in T-Cell Immunotherapy Business (2018-2023) & (US$ Million)
Table 78. Cellectis Recent Developments
Table 79. Juno Therapeutics Company Details
Table 80. Juno Therapeutics Business Overview
Table 81. Juno Therapeutics T-Cell Immunotherapy Product
Table 82. Juno Therapeutics Revenue in T-Cell Immunotherapy Business (2018-2023) & (US$ Million)
Table 83. Juno Therapeutics Recent Developments
Table 84. Kite Pharma Company Details
Table 85. Kite Pharma Business Overview
Table 86. Kite Pharma T-Cell Immunotherapy Product
Table 87. Kite Pharma Revenue in T-Cell Immunotherapy Business (2018-2023) & (US$ Million)
Table 88. Kite Pharma Recent Developments
Table 89. Novartis Company Details
Table 90. Novartis Business Overview
Table 91. Novartis T-Cell Immunotherapy Product
Table 92. Novartis Revenue in T-Cell Immunotherapy Business (2018-2023) & (US$ Million)
Table 93. Novartis Recent Developments
Table 94. Takara Bio Company Details
Table 95. Takara Bio Business Overview
Table 96. Takara Bio T-Cell Immunotherapy Product
Table 97. Takara Bio Revenue in T-Cell Immunotherapy Business (2018-2023) & (US$ Million)
Table 98. Takara Bio Recent Developments
Table 99. Unum Therapeutics Company Details
Table 100. Unum Therapeutics Business Overview
Table 101. Unum Therapeutics T-Cell Immunotherapy Product
Table 102. Unum Therapeutics Revenue in T-Cell Immunotherapy Business (2018-2023) & (US$ Million)
Table 103. Unum Therapeutics Recent Developments
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global T-Cell Immunotherapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global T-Cell Immunotherapy Market Share by Type: 2022 VS 2033
Figure 3. CAR-T Features
Figure 4. TCR Features
Figure 5. TIL Therapies Features
Figure 6. Global T-Cell Immunotherapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 7. Global T-Cell Immunotherapy Market Share by Application: 2022 VS 2033
Figure 8. Stomach Cancer Case Studies
Figure 9. Lung Cancer Case Studies
Figure 10. Colorectal Cancer Case Studies
Figure 11. Esophagus Cancer Case Studies
Figure 12. Pancreatic Cancer Case Studies
Figure 13. Others Case Studies
Figure 14. T-Cell Immunotherapy Report Years Considered
Figure 15. Global T-Cell Immunotherapy Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 16. Global T-Cell Immunotherapy Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 17. Global T-Cell Immunotherapy Market Share by Region: 2022 VS 2033
Figure 18. Global T-Cell Immunotherapy Market Share by Players in 2022
Figure 19. Global Top T-Cell Immunotherapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in T-Cell Immunotherapy as of 2022)
Figure 20. The Top 10 and 5 Players Market Share by T-Cell Immunotherapy Revenue in 2022
Figure 21. North America T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. North America T-Cell Immunotherapy Market Share by Type (2018-2033)
Figure 23. North America T-Cell Immunotherapy Market Share by Application (2018-2033)
Figure 24. North America T-Cell Immunotherapy Market Share by Country (2018-2033)
Figure 25. United States T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Canada T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. Europe T-Cell Immunotherapy Market Size YoY (2018-2033) & (US$ Million)
Figure 28. Europe T-Cell Immunotherapy Market Share by Type (2018-2033)
Figure 29. Europe T-Cell Immunotherapy Market Share by Application (2018-2033)
Figure 30. Europe T-Cell Immunotherapy Market Share by Country (2018-2033)
Figure 31. Germany T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. France T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. U.K. T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Italy T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Russia T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Nordic Countries T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. China T-Cell Immunotherapy Market Size YoY (2018-2033) & (US$ Million)
Figure 38. China T-Cell Immunotherapy Market Share by Type (2018-2033)
Figure 39. China T-Cell Immunotherapy Market Share by Application (2018-2033)
Figure 40. Asia T-Cell Immunotherapy Market Size YoY (2018-2033) & (US$ Million)
Figure 41. Asia T-Cell Immunotherapy Market Share by Type (2018-2033)
Figure 42. Asia T-Cell Immunotherapy Market Share by Application (2018-2033)
Figure 43. Asia T-Cell Immunotherapy Market Share by Region (2018-2033)
Figure 44. Japan T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. South Korea T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. China Taiwan T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Southeast Asia T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. India T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Australia T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Size YoY (2018-2033) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Share by Type (2018-2033)
Figure 52. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Share by Application (2018-2033)
Figure 53. Middle East, Africa, and Latin America T-Cell Immunotherapy Market Share by Country (2018-2033)
Figure 54. Brazil T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Mexico T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Turkey T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Saudi Arabia T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. Israel T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. GCC Countries T-Cell Immunotherapy Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 60. Adaptimmune Revenue Growth Rate in T-Cell Immunotherapy Business (2018-2023)
Figure 61. Altor Bioscience Corporation Revenue Growth Rate in T-Cell Immunotherapy Business (2018-2023)
Figure 62. Cellectis Revenue Growth Rate in T-Cell Immunotherapy Business (2018-2023)
Figure 63. Juno Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2018-2023)
Figure 64. Kite Pharma Revenue Growth Rate in T-Cell Immunotherapy Business (2018-2023)
Figure 65. Novartis Revenue Growth Rate in T-Cell Immunotherapy Business (2018-2023)
Figure 66. Takara Bio Revenue Growth Rate in T-Cell Immunotherapy Business (2018-2023)
Figure 67. Unum Therapeutics Revenue Growth Rate in T-Cell Immunotherapy Business (2018-2023)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries